| Primary information |
|---|
| ID | 11715 |
| Uniprot ID | P82972 |
| Description | Natriuretic peptide PNP |
| Organism | Pseudocerastes persicus |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria (diapsids); Lepidosauria (lepidosaurs); Squamata (squamates); Bifurcata (split-tongued squamates); Unidentata; Episquamata; Toxicofera; Serpentes (snakes); Colubroidea; Viperidae; Viperinae (vipers); Pseudocerastes; Pseudocerastes persicus (Persian horned vipe |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the natriuretic peptide family. |
| Tissue Specificity | Expressed by the venom gland. |
| Post Translational Modification | NA |
| Function | Increases urine flow and decreases blood pressure when administered to rats by intravenous injection. Inhibits thrombin-induced platelet aggregation. Stimulates cGMP production via the natriuretic peptide receptor-A (NPR1). |
| Length | 37 |
| Molecular Weight | 3 |
| Name | Natriuretic peptide PNP |
| Sequence | GENEPPKKKAPDGCFGHKIDRIGSHSGLGCNKFKPGH |
| Sequence map | 37 |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|